Similar articles for PMID: 32281052

Year	Number of Results
2013	1
2014	1
2020	87
2021	46
2022	31
2023	5
2024	2

1

Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.

Golchin A, Seyedjafari E, Ardeshirylajimi A. Golchin A, et al. Stem Cell Rev Rep. 2020 Jun;16(3):427-433. doi: 10.1007/s12015-020-09973-w. Stem Cell Rev Rep. 2020. PMID: 32281052 Free PMC article. Review.

2

Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.

Zayed M, Iohara K. Zayed M, et al. Cell Transplant. 2020 Jan-Dec;29:963689720952089. doi: 10.1177/0963689720952089. Cell Transplant. 2020. PMID: 32830527 Free PMC article. Review.

3

CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.

Ulrich H, Pillat MM. Ulrich H, et al. Stem Cell Rev Rep. 2020 Jun;16(3):434-440. doi: 10.1007/s12015-020-09976-7. Stem Cell Rev Rep. 2020. PMID: 32307653 Free PMC article. Review.

4

Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.

Jayaramayya K, Mahalaxmi I, Subramaniam MD, Raj N, Dayem AA, Lim KM, Kim SJ, An JY, Lee Y, Choi Y, Raj A, Cho SG, Vellingiri B. Jayaramayya K, et al. BMB Rep. 2020 Aug;53(8):400-412. doi: 10.5483/BMBRep.2020.53.8.121. BMB Rep. 2020. PMID: 32731913 Free PMC article. Review.

5

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.

Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T, Huang L, Zhao P, Yuan X, Fan X, Zhang JY, Song J, Zhang D, Jiao Y, Liu L, Zhou C, Maeurer M, Zumla A, Shi M, Wang FS. Meng F, et al. Signal Transduct Target Ther. 2020 Aug 27;5(1):172. doi: 10.1038/s41392-020-00286-5. Signal Transduct Target Ther. 2020. PMID: 32855385 Free PMC article. Clinical Trial.

6

Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.

Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, Meng M, Wu T, Liu D, Tian S, Tian H, Chen S, Zhou C. Zhang Y, et al. Stem Cell Res Ther. 2020 May 27;11(1):207. doi: 10.1186/s13287-020-01725-4. Stem Cell Res Ther. 2020. PMID: 32460839 Free PMC article.

7

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.

Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rogers CJ, et al. J Transl Med. 2020 May 18;18(1):203. doi: 10.1186/s12967-020-02380-2. J Transl Med. 2020. PMID: 32423449 Free PMC article. Review.

8

Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.

Li C, Zhao H, Wang B. Li C, et al. Drug Des Devel Ther. 2020 Sep 29;14:3995-4001. doi: 10.2147/DDDT.S269407. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33061304 Free PMC article.

9

Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.

Atluri S, Manchikanti L, Hirsch JA. Atluri S, et al. Pain Physician. 2020 Mar;23(2):E71-E83. Pain Physician. 2020. PMID: 32214286 Free article.

10

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.

Song N, Wakimoto H, Rossignoli F, Bhere D, Ciccocioppo R, Chen KS, Khalsa JK, Mastrolia I, Samarelli AV, Dominici M, Shah K. Song N, et al. Stem Cells. 2021 Jun;39(6):707-722. doi: 10.1002/stem.3354. Epub 2021 Mar 7. Stem Cells. 2021. PMID: 33586320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year